Skip to main content

Peer Review reports

From: Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Original Submission
30 Oct 2018 Submitted Original manuscript
16 Jan 2019 Author responded Author comments - Farastuk Bozorgmehr
Resubmission - Version 2
16 Jan 2019 Submitted Manuscript version 2
8 Apr 2019 Author responded Author comments - Farastuk Bozorgmehr
Resubmission - Version 3
8 Apr 2019 Submitted Manuscript version 3
14 May 2019 Reviewed Reviewer Report - Joachim Aerts
30 May 2019 Reviewed Reviewer Report - Reviewer 2
19 Sep 2019 Author responded Author comments - Farastuk Bozorgmehr
Resubmission - Version 4
19 Sep 2019 Submitted Manuscript version 4
24 Sep 2019 Author responded Author comments - Farastuk Bozorgmehr
Resubmission - Version 5
24 Sep 2019 Submitted Manuscript version 5
Publishing
25 Sep 2019 Editorially accepted
8 Nov 2019 Article published 10.1186/s12885-019-6205-0

You can find further information about peer review here.

Back to article page